No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
www.circio.comNo one on the platform currently holds CRNA.OL.
No tracked institution reports a position in CRNA.OL as of their last filing.
No one on the platform has traded CRNA.OL yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | — | $0.00 | $0.00–$0.00 | — | 1 |
| 2027 | $0 | — | $0.00 | $0.00–$0.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-05-11 | $-0.20 | $-0.28 | -40.0% |
| 2022-02-17 | $-0.20 | $-0.28 | -40.0% |
| 2021-11-04 | $-0.23 | $-0.19 | +17.4% |
| 2021-08-18 | $-0.23 | $-0.21 | +8.7% |
| +0.00% |
| $3M |
| — |
| PHO.OLPhotocure ASA | $51.50 | +0.78% | $1.4B | — |
Source: Financial Modeling Prep · peers by sector/industry